Press Releases about Qiagen N.V.
QIAGEN N.V. to release results for Q1 2022 and hold Webcast
April 20, 2022
From QIAGEN N.V.
Via Business Wire
From QIAGEN N.V.
Via Business Wire
QIAGEN Announces 20-F Annual Report Filing for 2021 Results
March 14, 2022
From QIAGEN N.V.
Via Business Wire
QIAGEN N.V. to release results for Q4 2021 and Full-Year of 2021
January 19, 2022
From QIAGEN N.V.
Via Business Wire
From QIAGEN N.V.
Via Business Wire
QIAGEN Expands QuantiFERON Portfolio in the Fight Against TB
January 06, 2022
From QIAGEN N.V.
Via Business Wire
Rising Test Accuracy Standards Needed as On-Site Demand for Covid-19 Testing Increases
November 09, 2021
Exposures
COVID-19
QIAGEN and BD Settle Patent Infringement Lawsuit
November 05, 2021
From QIAGEN N.V.
Via Business Wire
From QIAGEN N.V.
Via Business Wire
From QIAGEN N.V.
Via Business Wire
From QIAGEN N.V.
Via Business Wire
QIAGEN Launches Novel QIAreach QuantiFERON-TB Tuberculosis Test for High-Burden Regions
October 19, 2021
From QIAGEN N.V.
Via Business Wire
Big Changes Coming to Covid Testing in Response to Rising Demand Under Latest Mandates
September 28, 2021
Exposures
COVID-19
Why New Covid-19 Test Supplies Will Be Needed Soon in Wake of US President’s New OSHA Mandates
September 14, 2021
Exposures
COVID-19
QIAGEN to Enter the DAX – Germany’s Leading Stock Market Index
September 03, 2021
From QIAGEN N.V.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.